SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Ros M M) srt2:(2000-2004)"

Search: WFRF:(Ros M M) > (2000-2004)

  • Result 1-8 of 8
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Ericson, Marica, 1974, et al. (author)
  • Photodynamic therapy of actinic keratosis at varying fluence rates : Assessment of photobleaching, pain and primary clinical outcome
  • 2004
  • In: British Journal of Dermatology. - : Oxford University Press (OUP). - 0007-0963 .- 1365-2133. ; 151, s. 1204-1212
  • Journal article (peer-reviewed)abstract
    • Background: Although photodynamic therapy (PDT) is becoming an important treatment method for skin lesions such as actinic keratosis (AK) and superficial basal cell carcinoma, there are still discussions about which fluence rate and light dose are preferable. Recent studies in rodents have shown that a low fluence rate is preferable due to depletion of oxygen at high fluence rates. However, these results have not yet been verified in humans. Objectives: The objective was to investigate the impact of fluence rate and spectral range on primary treatment outcome and bleaching rate in AK using aminolaevulinic acid PDT. In addition, the pain experienced by the patients has been monitored during treatment. Patients/methods Thirty-seven patients (mean age 71 years) with AK located on the head, neck and upper chest were treated with PDT, randomly allocated to four groups: two groups with narrow filter (580-650 nm) and fluence rates of 30 or 45 mW cm-2, and two groups with broad filter (580-690 nm) and fluence rates of 50 or 75 mW cm-2. The total cumulative light dose was 100 J cm-2 in all treatments. Photobleaching was monitored by fluorescence imaging, and pain experienced by the patients was registered by using a visual analogue scale graded from 0 (no pain) to 10 (unbearable pain). The primary treatment outcome was evaluated at a follow-up visit after 7 weeks. Results: Our data showed a significant correlation between fluence rate and initial treatment outcome, where lower fluence rate resulted in favourable treatment response. Moreover, the photo-bleaching dose (1/e) was found to be related to fluence rate, ranging from 4.5 ± 1.0 J cm -2 at 30 mW cm-2, to 7.3 ± 0.7 J cm-2 at 75 mW cm-2, indicating higher oxygen levels in tissue at lower fluence rates. After a cumulative light dose of 40 J cm-2 no further photobleaching took place, implying that higher doses are excessive. No significant difference in pain experienced by the patients during PDT was observed in varying the fluence rate from 30 to 75 mW cm-2. However, the pain was found to be most intense up to a cumulative light dose of 20 J cm-2. Conclusions: Our results imply that the photobleaching rate and primary treatment outcome are dependent on fluence rate, and that a low fluence rate (30 mW cm-2) seems preferable when performing PDT of AK using noncoherent light sources.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Perez-Torres, M. A., et al. (author)
  • High-resolution radio imaging of young supernovae
  • 2004
  • Reports (other academic/artistic)abstract
    • The high resolution obtained through the use of VLBI gives an unique opportunity to directly observe the interaction of an expanding radio supernova with its surrounding medium. We present here results from our VLBI observations of the young supernovae SN 1979C, SN 1986J, and SN 2001gd.
  •  
6.
  • Wiegleb Edström, Desirée, 1959-, et al. (author)
  • Flashlamp pulsed dye laser and argon-pumped dye laser in the treatment of port-wine stains a clinical and histological comparison
  • 2002
  • In: British Journal of Dermatology. - : Wiley-Blackwell Publishing Inc.. - 0007-0963 .- 1365-2133. ; 146:2, s. 285-289
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Port-wine stains (PWS) are congenital vascular malformations occurring in 0.3% of children. The pulsed dye laser is a well established treatment for PWS.OBJECTIVES: To compare, clinically and histologically, the effects of the flashlamp pulsed dye laser with the argon-pumped dye laser in the treatment of PWS.METHODS: Thirty patients were treated on two to four test areas with both laser types using different energy fluences. A flashlamp pulsed dye laser with 0.45 ms pulse duration and a spot size of 5 mm was compared with an argon-pumped dye laser, with a spot size of 1 mm delivered with a robotic scanning laser handpiece (Hexascan) and 70-190 ms pulse duration. Both were tuned to 585 nm. Twelve weeks later the degree of lightening was evaluated and biopsies were taken. To count the vessels the skin sections were stained with CD34 using an immunohistochemical technique. The vessels were divided into three groups by diameter (d): d < 10 microm, 10 < or = d < 20 microm, d > or = 20 microm.RESULTS: The clinical results showed a significantly better lightening using the flashlamp pulsed dye laser than with the argon-pumped dye laser. The histological results showed a significant decrease in the number of vessels of diameter larger than 20 microm in treated compared with untreated lesions. We found no histological difference in the number of vessels between the two laser treatments. However, there was a tendency towards more small vessels (diameter < 10 microm) after one treatment with the flashlamp pulsed dye laser compared with untreated PWS.CONCLUSIONS: The flashlamp pulsed dye laser is clinically superior to the argon-pumped dye laser in the treatment of PWS.
  •  
7.
  • Wiegleb Edström, Desirée, 1959-, et al. (author)
  • Effects on human skin of repetitive ultraviolet-A1 (UVA1) irradiation and visible light.
  • 2001
  • In: Photodermatology, Photoimmunology & Photomedicine. - : Wiley-Blackwell Publishing Inc.. - 0905-4383 .- 1600-0781. ; 17:2, s. 66-70
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Ultraviolet radiation (UVR) has a variety of effects on human skin. Best known are the effects of UVB (290-320 nm) and UVA2 (320-340 nm), which cause DNA damage and increased risk of cancer. However, the effects of UVA1 (340-400 nm) have been not completely investigated.METHODS: The effects of repetitive low doses of UVA1 and visible light were studied in 12 healthy individuals. A part of the buttock was exposed to 20 J/cm2 UVA1 and another part of 126 J/cm2 of visible light three times a week for 4 weeks. Repeated punch biopsies were taken during the 4 weeks of treatment and also 2 weeks after the last irradiation. The avidin-biotin-immunoperoxidase technique was used to investigate the expression of p53, p21WAF, bcl-2, Ki67 and cyclin A.RESULTS: By comparison to untreated skin, an increased expression of p53 but not p21WAF in keratinocytes was seen. The bcl-2 protein expression increased slightly after both UVA1 and visible light. An increased staining with Ki67 and cyclin A after UVA1 but not after visible light was observed as a sign of increased proliferation.CONCLUSION: These results suggest that suberythemal doses of UVA1 and even visible light may cause DNA damage.
  •  
8.
  • Wiegleb Edström, Desirée, 1959-, et al. (author)
  • Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides : clinical and histological response
  • 2001
  • In: Acta Dermato-Venereologica. - : Taylor & Francis. - 0001-5555 .- 1651-2057. ; 81:3, s. 184-188
  • Journal article (peer-reviewed)abstract
    • There is no curative treatment for mycosis fungoides (MF), the most common primary cutaneous T-cell lymphoma. The aim of this study was to investigate the response of single lesions to photodynamic therapy (PDT). The study included 10 plaque MF lesions and 2 tumour MF lesions from 10 patients. First, 20% 5-aminolevulinic acid was applied topically to the lesion and adjacent skin for 5-6 h. The lesion was then exposed to red light at around 630nm. Skin biopsies were taken before treatment, after clinical improvement and after clinical remission. The expression of CD3, CD4, CD7, CD8, CD1a, CD34, CD68, CD71, Ki-67, bcl-2 and p53 was studied immunohistochemically. There was complete clinical clearance in seven of nine plaque lesions. Neither tumour lesion responded to PDT. The biopsies confirmed a regression of the infiltrate after treatment. In the sparse remaining infiltrate a few CD4+ and CD8+ cells were found, most of which showed normal bcl-2. There were also fewer proliferating cells, illustrated by a decrease in Ki-67 and CD71. In conclusion, PDT has good clinical and histological effects in treating local plaque MF lesions.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-8 of 8
Type of publication
journal article (6)
reports (2)
Type of content
peer-reviewed (6)
other academic/artistic (2)
Author/Editor
Ros, A-M (4)
Wiegleb Edström, Des ... (3)
Porwit, A (2)
Lundqvist, P (1)
Ros, E. (1)
Hosseini, A. (1)
show more...
Stark, K. (1)
Marcaide, J.M. (1)
Guirado, J. C. (1)
Perez-Torres, M. A. (1)
Sundell-Bergman, S (1)
Karlsson, M (1)
Rosen, Arne, 1939 (1)
Van Dyk, S. D. (1)
Alberdi, A. (1)
Gilek, Michael (1)
Garnier-Laplace, Jac ... (1)
Panagia, N. (1)
Rosdahl, Inger, 1943 ... (1)
Thørring, H. (1)
Witthöft, Cornelia M ... (1)
Brown, Justin (1)
Shapiro, I.I. (1)
Lara, L. (1)
Diamond, P. J. (1)
Calmon, P (1)
Ericson, Marica, 197 ... (1)
Fortin, C (1)
Kautsky, Ulrik (1)
Oughton, Deborah (1)
Strand, Per (1)
Weiler, K. W (1)
Mantovani, F. (1)
Sandberg, Carin, 196 ... (1)
Walker, C. (1)
Stenquist, B. (1)
Larkö, Olle, 1952 (1)
Jones, Celia (1)
Gudmundson, F. (1)
Wennberg, A-M (1)
Fontal-Cazalla, F.M. ... (1)
Larsson, Carl-Magnus (1)
Ros, G (1)
Bruchertseifer, F (1)
Havenaar, R (1)
Verwei, M (1)
Olivares, A B (1)
Arkbage, K (1)
Carnovale, E (1)
Kariluoto, S (1)
show less...
University
Karolinska Institutet (4)
Örebro University (3)
University of Gothenburg (1)
Uppsala University (1)
Stockholm University (1)
Linköping University (1)
show more...
Södertörn University (1)
Chalmers University of Technology (1)
Linnaeus University (1)
show less...
Language
English (8)
Research subject (UKÄ/SCB)
Medical and Health Sciences (4)
Engineering and Technology (1)
Agricultural Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view